Qiagen N.V. SEC filings QGEN
Qiagen N.V. has 513 filings in SEC EDGAR's recent list, going back to Oct 6, 1998. Its latest annual report, Form 20-F, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 6, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-C | Filing | Oct 28, 2026 | — |
| SC TO-C | Filing | Oct 22, 2026 | — |
| SC14D9C | Form sc14d9c | Oct 22, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| IRANNOTICE | Filing | Mar 20, 2026 | — |
| 25-NSE/A | Filing | Jan 9, 2026 | — |
| 25-NSE | Delisting notice | Jan 8, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2025 | — |
| IRANNOTICE | Filing | Mar 31, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| IRANNOTICE | Filing | Mar 11, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2023 | — |
| IRANNOTICE | Filing | May 5, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2022 | — |
| IRANNOTICE | Filing | Mar 14, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | Mar 26, 2021 | — |
| IRANNOTICE | Filing | Mar 5, 2021 | — |
| SC 14D9/A | Filing | Aug 13, 2020 | — |
| SC TO-T/A | Filing | Aug 13, 2020 | — |
| SC TO-T/A | Filing | Aug 11, 2020 | — |
| SC TO-T/A | Filing | Aug 10, 2020 | — |
| SC TO-T/A | Filing | Aug 7, 2020 | — |
| SC TO-T/A | Filing | Aug 6, 2020 | — |
| SC TO-T/A | Amendment no 19 to schedule to | Aug 5, 2020 | — |
| SC 14D9/A | Filing | Aug 5, 2020 | — |
| SC TO-T/A | Filing | Aug 4, 2020 | — |
| SC TO-T/A | Filing | Aug 3, 2020 | — |
| SC TO-T/A | Amendment no. 16 to schedule to | Jul 27, 2020 | — |
| SC TO-T/A | Filing | Jul 23, 2020 | — |
| SC 14D9/A | Filing | Jul 22, 2020 | — |
| SC TO-T/A | Filing | Jul 20, 2020 | — |
| SC TO-T/A | Filing | Jul 17, 2020 | — |
| SC 14D9/A | Filing | Jul 16, 2020 | — |
| SC TO-T/A | Filing | Jul 16, 2020 | — |
| SC TO-T/A | Filing | Jul 13, 2020 | — |
| SC TO-T/A | Schedule to | Jul 6, 2020 | — |
| SC TO-T/A | Filing | Jul 1, 2020 | — |
| SC TO-T/A | Filing | Jun 29, 2020 | — |
| SC TO-T/A | Filing | Jun 22, 2020 | — |
| SC TO-T/A | Filing | Jun 15, 2020 | — |
| SC 14D9/A | Filing | Jun 15, 2020 | — |
| SC TO-T/A | Filing | Jun 8, 2020 | — |
| SC TO-T/A | Filing | Jun 2, 2020 | — |
| SC TO-T/A | Filing | May 26, 2020 | — |
| SC 14D9 | Filing | May 18, 2020 | — |
| SC TO-T/A | Filing | May 18, 2020 | — |
| SC TO-T/A | Filing | May 11, 2020 | — |
| SC TO-T | Filing | Apr 28, 2020 | — |
| SC TO-C | Filing | Apr 23, 2020 | — |
| SD | Specialized disclosure (conflict minerals) | Mar 30, 2020 | — |
| SC TO-C | Filing | Mar 9, 2020 | — |
| SC TO-C | Filing | Mar 3, 2020 | — |
| SC14D9C | Filing | Mar 3, 2020 | — |
| SC TO-C | Filing | Mar 3, 2020 | — |
| IRANNOTICE | Filing | Mar 2, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2019 | — |
| CORRESP | Letter to the SEC | Sep 25, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2019 | — |
| SD | Specialized disclosure (conflict minerals) | May 8, 2019 | — |
| IRANNOTICE | Filing | Mar 6, 2019 | — |
| SD | Specialized disclosure (conflict minerals) | May 17, 2018 | — |
| IRANNOTICE | Filing | Mar 6, 2018 | — |
| 25 | Form 25 | Jan 8, 2018 | — |
| CERT | Qgen nyse certification | Jan 3, 2018 | — |
| 8-A12B | Filing | Dec 20, 2017 | — |
| SD | Specialized disclosure (conflict minerals) | Apr 24, 2017 | — |
| IRANNOTICE | Filing | Mar 6, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2016 | — |
| CORRESP | Letter to the SEC | Aug 8, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2016 | — |
| SD | Specialized disclosure (conflict minerals) | May 25, 2016 | — |
| IRANNOTICE | Filing | Feb 29, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 5, 2015 | — |
| CORRESP | Letter to the SEC | Oct 8, 2015 | — |
| CORRESP | Letter to the SEC | Aug 24, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2015 | — |
| SD | Specialized disclosure (conflict minerals) | Apr 1, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2014 | — |
| CORRESP | Letter to the SEC | Jun 6, 2014 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2014 | — |
| UPLOAD | Letter from the SEC | May 29, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2013 | — |
| CORRESP | Letter to the SEC | Jul 11, 2013 | — |
| CORRESP | Letter to the SEC | Jul 3, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2013 | — |
| CORRESP | Letter to the SEC | May 24, 2013 | — |
| UPLOAD | Letter from the SEC | May 14, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2010 | — |
| CORRESP | Letter to the SEC | May 25, 2010 | — |
| UPLOAD | Letter from the SEC | May 17, 2010 | — |
| UPLOAD | Letter from the SEC | Oct 1, 2007 | — |
| CORRESP | Letter to the SEC | Aug 31, 2007 | — |
| CORRESP | Letter to the SEC | Jul 31, 2007 | — |
| SC TO-T/A | Amendment no. 3 to sc to-t | Jul 26, 2007 | — |
| 425 | Rule 425 | Jul 26, 2007 | — |
| EFFECT | Filing | Jul 23, 2007 | — |
| 425 | Press release | Jul 23, 2007 | — |
| CORRESP | Letter to the SEC | Jul 20, 2007 | — |
| 425 | Rule 425 | Jul 20, 2007 | — |
| SC TO-T/A | Amendment no. 2 to sc to-t | Jul 18, 2007 | — |
| 425 | Form 425 | Jul 17, 2007 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2007 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2007 | — |
| 425 | Rule 425 | Jul 13, 2007 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2007 | — |
| SC TO-T/A | Amendment no. 1 to schedule to | Jul 5, 2007 | — |
| 425 | Rule 425 | Jul 3, 2007 | — |
| SC TO-T | Schedule to-t | Jun 15, 2007 | — |
| EFFECT | Filing | Jun 6, 2007 | — |
| 425 | Form 425 | Jun 4, 2007 | — |
| 425 | Form 425 | Jun 4, 2007 | — |
| CORRESP | Letter to the SEC | Jun 4, 2007 | — |
| 425 | Rule 425 | Jun 4, 2007 | — |
| 425 | Rule 425 | Jun 4, 2007 | — |
| 425 | Rule 425 | Jun 4, 2007 | — |
| 425 | Rule 425 | Jun 4, 2007 | — |
| 425 | Rule 425 | Jun 4, 2007 | — |
| 425 | Rule 425 | Jun 4, 2007 | — |
| 425 | Rule 425 | Jun 4, 2007 | — |
| 425 | Rule 425 | Jun 4, 2007 | — |
| UPLOAD | Letter from the SEC | May 23, 2007 | — |
| CORRESP | Letter to the SEC | Oct 21, 2005 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2005 | — |
| CORRESP | Letter to the SEC | Aug 22, 2005 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2005 | — |
| RW | Form rw | Mar 27, 2003 | — |
| RW | Form rw | Mar 27, 2003 | — |
| REGDEX | Auto-generated paper document | Apr 30, 2002 | — |
Showing 128 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- QGEN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Pl Venlo
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1015820
- Former names
- QIAGEN NV (until Feb 14, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.